Sarah Maenhout

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Sandra Van Lint, Cleo Goyvaerts, Sarah Maenhout et al. · Cancer Research · 2012 · 210 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety

Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski et al. · ACS Nano · 2018 · 135 citations · Full text

Pharmacy, Immunology, Pharmaceutics +17

Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

Sandra Van Lint, Dries Renmans, Katrijn Broos et al. · Cancer Immunology Research · 2016 · 128 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced suppressive capacity of tumor‐infiltrating myeloid‐derived suppressor cells compared with their peripheral counterparts

Sarah Maenhout, Sandra Van Lint, Perpetua U. Emeagi et al. · International Journal of Cancer · 2013 · 78 citations · Full text

Life Sciences, Immunology, Oncology +17

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model

Stephanie Du Four, Sarah Maenhout, Kari De Pierre et al. · OncoImmunology · 2015 · 73 citations · Full text

Medicine, Immunology, Oncology +17